Erratum to: The human protein p19ARF is not detected in hemopoietic human cell lines that abundantly express the alternative β transcript of the p16INK4a/MTS1 gene (Oncogene, (1997), 15, 20, (2475-2481), 10.1038/sj.onc.1201417);The human protein p19(ARF) is not detected in hemopoietic human cell lines that abundantly express the alternative β transcript of the p16(INK4a)/MTS1 gene

Oncogene

Volumn 15, Issue 20, 1997, Pages 2475-2481

  Della Valle, Véronique ^a   Duro, Dominique ^a   Bernard, Olivier ^a   Larsen, Christian Jacques ^a  

^a INSERM   (France)

Author keywords

CDKN2; MTS1; p16(INK4a); p19(ARF)

Indexed keywords

CYCLIN DEPENDENT KINASE; POLYCLONAL ANTIBODY; MESSENGER RNA; PROTEIN; PROTEIN P14ARF; PROTEIN P16INK4A; RNA; TUMOR PROTEIN;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL LINE; FIBROBLAST; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; BURKITT LYMPHOMA; CELL AGING; CELL CULTURE; CELL STRAIN COS1; CHILD; CHROMOSOME 9; COMPARATIVE STUDY; ERYTHROLEUKEMIA; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEMATOPOIETIC STEM CELL; LEUKEMIA; MALE; MEGAKARYOCYTE; METABOLISM; MOUSE; PATHOLOGY; PROTEIN SYNTHESIS;

ANIMALS; BURKITT LYMPHOMA; CELL AGING; CHILD; CHROMOSOMES, HUMAN, PAIR 9; COS CELLS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FIBROBLASTS; GENE EXPRESSION REGULATION; GENES; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MALE; MEGAKARYOCYTES; MICE; NEOPLASM PROTEINS; PROTEIN BIOSYNTHESIS; PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0030613005     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1201767     Document Type: Erratum

References (29)

1. Alcorta DA, Xiong D, Phelps D, Hannon G, Beach D and Barrett JC. (1996). Proc. Natl. Acad. Sci. USA, 93, 13742-13747.
2. Boulukoz KE, Pognonec P, Rabault B, Begue A and Ghysdael J. (1989). Mol. Cell. Biol., 9, 995-1008.
3. Coleman A, Fountain JW, Nobori T, Olopade OI, Robertson G, Housman DE and Lugo TG. (1994). Cancer Res., 54, 344-348.
4. Coligan JE, Dunn BM, Ploegh HL, Speicher DW and Wingfield PT. (1995). Current protocols in Protein Science, Vol 1, J. Wiley and Sons, Inc.
5. Duro D, Bernard O, Della Valle V, Berger R and Larsen C-J. (1995). Oncogene, 11, 21-29.
6. Duro D, Bernard O, Della Valle V, Leblanc T, Berger R and Larsen C-J. (1996). Cancer Res., 56, 848-854.
7. Fitzgerald MG, Harkin DP, Siva-Arrieta S, MacDonald DJ, Isselbacher KJ, Sober AJ and Haber DA. (1996). Proc. Natl. Acad. Sci. USA, 93, 8541-8545.
8. Flores JF, Walker GJ, Glendening JM, Haluska FG, Castresana JS, Rubio M-P, Pastorfide GC, Boyer LA, Kao WH, Bulyk M, Barnhill RL, Hayward NK, Housman DE and Fountain JW. (1996). Cancer Res., 56, 5023-5032.
9. Hara E, Smith R, Parry D, Tahara H, Stone S and Peters G. (1996). Mol. Cell. Biol., 16, 859-867.
10. Hui AM, Sakamoto M, Kanai Y, Ino Y, Gotoh M, Yokota J and Hirohashi S. (1996). Hepatology, 24, 575-579.
11. Koh J, Enders GH, Dynlacht BD and Harlow E. (1995). Nature, 375, 506-510.
12. Larsen C-J. (1996). Oncogene, 12, 2041-2044.
13. Liggett WH Jr, Sewell DA, Rocco J, Ahrendt SA, Koch W and Sidransky D. (1996). Cancer Res., 56, 4119-4123.
14. Linardopoulos S, Street AJ, Quelle DE, Parry D, Peters G and Sherr CJ. (1995). Cancer Res., 55, 5168-5172.
15. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM and Pagano M. (1997). Nature Med., 3, 231-234.
16. Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ and Sidransky D. (1995). Cancer Res., 55, 2995-2997.
17. Olopade OI, Bohlander SK, Pomykala H, Maltepe E, Van Melle E, Le Beau MM and Diaz MO. (1992). Genomics, 14, 437-443.
18. Parry D and Peters G. (1996). Mol. Cell. Biol., 16, 3844-3852.
19. Quelle DE, Zindy F, Ashmun RA and Sherr CJ. (1995). Cell, 83, 993-1000.
20. Quelle DE, Cheng M, Ashmun R and Sherr CJ. (1997). Proc. Natl. Acad. Sci. USA, 94, 669-673.
21. Reznikoff CA, Yeager TR, Belair CD, Savelieva E, Puthenveettil JA and Stadler WM. (1996). Cancer Res., 56, 2886-2890.
22. Sambrook J, Fritsch EF and Maniatis T. (1989). In Molecular cloning. Second edition, Cold Spring Harbor Laboratory Press.
23. Schägger H and von Jagow G. (1987). Analyt. Biochem., 166, 368-379.
24. Sherr CJ. (1996). Science, 274, 1672-1677.
25. Soulard M, Della Valle V, Siomi MC, Pinol-Roma S, Codogno P, Bauvy C, Bellini M, Monod G, Dreyfuss G and Larsen C-J. (1993). Nucleic Acids Res., 21, 4210-4218.
26. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G and Kamb A. (1995). Cancer Res., 55, 2988-2994.
27. Swafford DS, Middleton SK, Palmisano WA, Nikula KJ, Tesfaigzi J, Baylin SB, Herman JG and Belinsky SA. (1997). Mol. Cell. Biol., 17, 1366-1374.
28. Wick ST, Dubay MM, Imanil I and Brizuela L. (1995). Oncogene, 11, 2013-2019.
29. Zhou M, Gu L, James CD, He J, Yeager AM, Smith SD and Findley HW. (1995). Leukemia, 9, 1159-1161.